Hiperlipidemia: Perbedaan antara revisi

Konten dihapus Konten ditambahkan
Muhammad Anas Sidik (bicara | kontrib)
Tidak ada ringkasan suntingan
Tag: Suntingan perangkat seluler Suntingan peramban seluler Suntingan seluler lanjutan
Muhammad Anas Sidik (bicara | kontrib)
Tidak ada ringkasan suntingan
Tag: Suntingan perangkat seluler Suntingan peramban seluler Suntingan seluler lanjutan
Baris 71:
| rowspan="3" | Diet control
| rowspan="3" | Creamy top layer
| rowspan="3" | OneSatu indari 1,.000,.000<ref>{{cite web | title = Hyperlipoproteinemia, Type I | date = 6 March 2007 | url = http://www.cags.org.ae/FMPro?-DB=ctga.fp5&-Format=ctga%2Fctga_detail.html&-RecID=34563&-Find | archive-url = https://web.archive.org/web/20120327213629/http://www.cags.org.ae/FMPro?-DB=ctga.fp5&-Format=ctga%2Fctga_detail.html&-RecID=34563&-Find | archive-date=27 March 2012 | work = Centre for Arab Genomic Studies | quote = About 1:1,000,000 people are affected with Hyperlipoproteinemia type I worldwide with a higher prevalence in some regions of Canada. }}</ref>
|-
! b
Baris 92:
| [[Bile acid sequestrant]]s, [[statin]]s, [[niacin (substance)|niacin]]
| Clear
| OneSatu indari 500 foruntuk heterozygotesheterozigot
|-
! b
Baris 102:
| Statins, niacin, [[fibrate]]
| Turbid
| Onesatu indari 100
|-
! colspan="2" | Tipe III
Baris 112:
| Fibrate, statins
| Turbid
| Onesatu indari 10,.000<ref name="fung2011">{{cite journal | vauthors = Fung M, Hill J, Cook D, Frohlich J | title = Case series of type III hyperlipoproteinemia in children | journal = BMJ Case Reports | volume = 2011 | pages = bcr0220113895 | date = June 2011 | pmid = 22691586 | pmc = 3116222 | doi = 10.1136/bcr.02.2011.3895 }}</ref>
|-
! colspan="2" | Tipe IV
Baris 122:
| Fibrate, niacin, statins
| Turbid
| Onesatu indari 100
|-
! colspan="2" | Tipe V